Article
Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background.
Neurobiology of aging - 1 Feb 2011
Katzav Aviva, Faust-Socher Achinoam, Kvapil Filip, Michaelson Daniel M, Blank Miri, Pick Chaim G, Shoenfeld Yehuda, Korczyn Amos D, Chapman Joab
Abstract excerpt
The antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies (aPL) and vascular brain disease which is often associated with dementia. We examined the neurodegenerative pathological processes underlying APS by inducing APS in a transgenic animal model of Alzheimer's disease. Female C57B6/SJL mice carrying the APP(695)SWE mutation (Tg2576) and wild-type (wt) controls were immunized with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
